Blinded second-opinion for psychiatric diagnosis

Diagnoxal runs your case three ways: with prior diagnoses considered, without them, and side-by-side. See where anchoring is shaping the call before the call is final. DSM-5-TR and ICD-11 grounded.

Built on what you already use: DSM-5-TR criteria ICD-11 Structured differential Medical & substance rule-outs Risk formulation Documentation-ready output
Diagnostic Analysis 3 analyses a month with a free account. First case free, no account needed.
29-year-old ICU nurse case
  1. 01 Redact & Extract
  2. 02 Retrieve Criteria
  3. 03 Hypothesize
  4. 04 Match Evidence
  5. 05 Differential
  6. 06 Verify
  7. 07 Etiology Gate
  8. 08 Grounding Gate
  9. 09 Compile Validity
  10. 10 Reconcile

A full analysis takes about 15 minutes.

Machine-generated diagnostic report · condensed

Rule-outs (require decisive data before exclusion)

Decisive next data:

Read the complete report format below

One real case, condensed from a full run of about 15 minutes.

Diagnostic Analysis 3 analyses a month with a free account. First case free, no account needed.

The Problem and the Approach

The problem

A referred case arrives already labeled. This same case is read twice: once with the referral context and once with the prior label set aside. The two reads are compared before a final call, making any difference in the reasoning visible.

The approach

Diagnoxal re-analyzes the raw vignette with prior labels removed, checks every candidate against DSM-5-TR and ICD-11 criteria, and keeps the formulation provisional until medical and substance causes are addressed. It then compares that blinded analysis with one that saw the full context.

The result

A structured second opinion in minutes: a differential with quoted evidence, the tests and questions that would settle it, and documentation ready for the chart. If the two analyses disagree, you find out before the call is final.

Psychiatrists & physicians

A colleague-level second read with medical and substance rule-outs enforced on every case.

Clinical psychologists

Criterion-by-criterion reasoning you can carry into assessment, formulation, and testing decisions.

All mental-health professionals

The same reasoning discipline on every case, and a practice environment to sharpen your own.

A case before a conclusion

Read the complete case before the reasoning sequence.

Read the full vignette first. Then continue through the reasoning safeguards that test the same case before any final call. Amber marks the safety gates: they can only demote a conclusion, never promote one.

The reasoning sequence

How Diagnoxal reasons

The sequence below follows the same complete case through ten safeguards. Open any stage output to read its clinical prose at your own pace.

Stage 01

Redact & Extract

The referral label “anxiety not responding to medication” is set aside so it cannot anchor the read. Extracted: a 4-month course of abrupt fear episodes, now near-daily; 6 kg of unintentional weight loss; feeling hot all the time; a fine resting tremor; broken sleep; symptoms that worsened after the sertraline dose went up.

Extracted case summary

A four-month pattern of abrupt, intense-fear episodes includes pounding heartbeat, chest tightness, trembling, sweating, derealization, and nocturnal awakenings. Between episodes, the patient reports persistent hyperarousal, insomnia, irritability, and work-related racing thoughts.

  • Recent unintentional weight loss, heat intolerance, diaphoresis, and fine tremor are carried forward without assuming their cause.
  • Symptoms began after sertraline was started and worsened after its dose increased; daily pseudoephedrine and high caffeine exposure are also present.
  • Relevant context includes thyroid disease in a parent, bipolar disorder in a maternal aunt, occupational impairment, and passive thoughts of not waking up without intent or plan.

Stage 02

Retrieve Criteria

Relevant criterion sets are retrieved for every candidate before any matching begins: panic disorder, generalized anxiety, and anxiety due to another medical condition among them.

Reader-form criterion states

  • Recurrent unexpected panic attacks — Met. Abrupt fear episodes have recurred for about four months, including episodes that woke the patient from sleep.
  • Panic-attack symptom threshold — Met. Pounding heartbeat, chest tightness, trembling, sweating, and derealization are documented during attacks.
  • Potential medication, substance, or medical attribution — Insufficient information. The record does not show that those alternatives have been evaluated sufficiently to set them aside.
  • Laboratory evidence of thyroid hormone excess — Insufficient information. No current thyroid laboratory testing is reported.

Stage 03

Hypothesize

Several possibilities are raised at once, on purpose: panic disorder, generalized anxiety, anxiety due to a medical condition (a thyroid picture), substance or medication-induced anxiety (pseudoephedrine, heavy caffeine, possible SSRI activation), and a bipolar question from the family history.

Diagnostic reasoning and differential considerations

The recurring panic-like phenomenology and subsequent worry or behavioral change support considering a panic syndrome. The timing of onset after sertraline, worsening after a dose increase, and ongoing pseudoephedrine and high caffeine exposure make a medication- or substance-related explanation plausible.

Weight loss, heat intolerance, tremor, diaphoresis, and a family history of thyroid disease keep thyrotoxicosis in the differential. Family history of bipolar disorder and activation after an SSRI also call for collateral about prior elevated or expansive mood, decreased need for sleep, or increased goal-directed activity.

Stage 04

Match Evidence

Each criterion is tested against quoted text. Panic-attack features are met. The manic and hypomanic criteria are not met. The vignette states no distinct period of elevated mood was ever observed. The weight loss is recorded as present but not yet explained.

Criterion-by-criterion evidence

Predominant anxiety or panic symptoms Met
“For ~4 months she has had abrupt intense fear episodes lasting 15–30 minutes with pounding heartbeat, chest tightness, trembling hands, sweating, and derealization.”
Temporal relationship to potential exposures Met
“Symptoms began roughly one month after sertraline 50 mg was started and worsened after dose increased to 100 mg.”
Course after reducing suspected exposures Insufficient information
“No documented period of medication cessation with observation of symptom persistence” is available.
Functional impact Met
“She has called in sick three times this month” and has difficulty drawing medications because of tremor.
Evidence of a distinct manic or hypomanic episode Not met
The patient reports no lifetime period of distinct elevated or expansive mood, decreased need for sleep with increased energy, or unusual goal-directed activity; by her account, others have not observed one. Direct collateral is still needed.

Stage 05

Differential

A thyroid workup is warranted because weight loss, heat intolerance, tremor, and family history remain live findings. Bipolar spectrum disorders remain an open rule-out pending collateral; the recent weight loss is not assumed to be an anorexia relapse.

Client-facing differential status

Bipolar spectrum disorders (Bipolar I / Bipolar II) — evaluation for presence of manic or hypomanic episode
Rule out — still open. Collateral is needed to check for missed elevated or expansive mood, decreased need for sleep, or increased goal-directed activity.
Insomnia Disorder (evaluation) AND Generalized Anxiety Disorder (GAD) (evaluation)
Provisional working.
Anxiety Disorder Due to Another Medical Condition (rule-out: thyrotoxicosis)
Rule out — still open, with directed medical assessment needed.

Stage 06Gate

Verify

An adversarial self-check challenges the medication/substance-attribution working explanation: primary anxiety after the relationship end, an unevaluated thyroid cause, or stimulant effects could instead explain the presentation. The post-cessation course is unknown, so this working explanation is demoted, not promoted. The leading psychiatric label is demoted, not promoted.

Counterargument to the working explanation

Symptoms could represent a new primary anxiety disorder, including panic disorder or generalized anxiety, precipitated by the recent relationship end rather than medication effects. Persistent between-attack symptoms and nocturnal panic could reflect a primary illness.

Hyperthyroidism remains unevaluated despite weight loss, heat intolerance, tremor, and a family history of thyroid disease; it could explain autonomic symptoms. Heavy caffeine use and pseudoephedrine alone might instead be the principal contributors.

The symptom course after stopping sertraline or reducing suspected stimulant exposures is not known. These information gaps lower diagnostic certainty and call for close follow-up and targeted medication or substance changes to observe causal effects.

Stage 07Gate

Etiology Gate

Thyroid function (TSH / free T4) has not been drawn; daily pseudoephedrine and heavy caffeine are active; the sertraline dose rose six weeks ago. While a medical or substance cause is live, no primary psychiatric label is finalized; the formulation stays provisional.

Etiology-gate formulation

An anxiety syndrome remains a working formulation with etiology undetermined. Medical, substance, and psychiatric explanations remain under consideration, including possible thyrotoxicosis, panic disorder, and bipolar spectrum disorders.

Complete the directed medical and substance workup before attributing the presentation to a primary psychiatric condition.

Stage 08Gate

Grounding Gate

Every statement is checked back against the vignette. No recent physical examination or laboratory work is documented, so no results are invented. Missing data is named, not filled in.

Grounding limits and findings not fully explained

  • Document exact dates of sertraline initiation and dose increase, with a timeline of symptom onset relative to those dates.
  • Vital signs, a focused examination, and TSH/free T4 are needed; no thyroid function testing or recent physical or laboratory work is available in the report.
  • Medication or substance effects, thyroid disease, and panic phenomenology remain competing explanations until the directed workup is complete.
  • Findings not fully explained include weight loss with heat intolerance, tremor affecting medication preparation, absent recent examination or laboratory work, thyroid disease in the family, and nocturnal episodes.

Stage 09

Compile Validity

Client-facing statuses remain provisional while the medical and substance questions are open. Acute suicide risk is described as low; passive wishes are monitored with short-interval follow-up.

Client-facing status and risk formulation

Bipolar spectrum disorders and anxiety due to another medical condition remain open rule-outs. Insomnia Disorder and Generalized Anxiety Disorder remain provisional working considerations.

Acute suicide risk is described as low because there is no intent, plan, or history of attempts; passive wishes of not waking up when exhausted are still monitored. Arrange short-interval follow-up. Functional risk is significant because tremor affects medication preparation and missed shifts. Medical risk remains unanswered until thyroid testing and the other missing data are obtained.

Stage 10

Reconcile

With referral context and blinded to prior labels, the two analyses reach different formulations. That disagreement is a flag for re-evaluation before a final call.

Reconciliation

With referral context
Medication-induced movement disorder (akathisia) and SSRI-associated activation / medication-induced anxiety (sertraline-associated akathisia/activation).
Blinded to prior labels
Substance/Medication-Induced Anxiety Disorder (provisionally related to sertraline; possible contribution from pseudoephedrine and high caffeine).

The analyses disagree. The difference suggests that prior diagnostic labels or treatment history may be anchoring clinical reasoning rather than independently supporting a call.

Treat the difference as a flag for re-evaluation: review the independent reasoning before committing to a final call, and consider collateral history, a structured re-interview, or formal psychometric testing to resolve it.

The complete report

Anxiety Disorder (provisional — etiology undetermined)

Anxiety syndrome with panic-like episodes: provisional, etiology undetermined.

Differential diagnoses

Bipolar spectrum disorders (Bipolar I / Bipolar II) — evaluation for presence of manic or hypomanic episode
Rule out — still open.
Insomnia Disorder (evaluation) AND Generalized Anxiety Disorder (GAD) (evaluation)
Provisional working.
Anxiety Disorder Due to Another Medical Condition (rule-out: thyrotoxicosis)
Rule out — still open.

Concurrent considerations

Medical, substance-related, and primary psychiatric explanations remain under evaluation. The presentation should not be attributed to a primary psychiatric condition while the medical and substance workup is incomplete.

Open rule-outs and decisive next data

The report’s rule-out list remains open while decisive information is gathered:

  • Bipolar spectrum disorders: obtain collateral about past elevated or expansive mood, decreased need for sleep, and increased goal-directed activity.
  • Insomnia Disorder (evaluation) AND Generalized Anxiety Disorder (GAD) (evaluation)
  • Anxiety Disorder Due to Another Medical Condition (rule-out: thyrotoxicosis)
  • Thyrotoxicosis (possible hyperthyroidism)
  • Panic Disorder, provisional (pending evaluation for substance/medical causes)
  • Thyrotoxicosis/Hyperthyroidism (dangerous to miss)
  • Sympathomimetic (pseudoephedrine/caffeine) toxicity with cardiac complications (dangerous to miss)
  • Primary Panic Disorder with functional impairment (dangerous to miss)
  • Relapse of Anorexia Nervosa with medical instability (dangerous to miss)
  • Cardiac arrhythmia/ischemia (dangerous to miss)

Decisive next data

  • Obtain vital signs, a focused physical examination, and up-to-date TSH/free T4 testing.
  • Document the treatment timeline; immediately discontinue pseudoephedrine and substantially reduce caffeine, with prescriber-guided review of sertraline, then observe the symptom course.
  • Reassess for persistence or resolution of panic symptoms after potential medication, substance, and medical causes have been evaluated.

Suggested instruments

  • C-SSRS — Columbia Suicide Severity Rating Scale: Structured suicide risk assessment (clinician-administered).
  • MDQ — Mood Disorder Questionnaire: Screening for lifetime manic or hypomanic episodes (self-report).
  • YMRS — Young Mania Rating Scale: Current manic symptom severity (clinician-administered).
  • GAD-7 — Generalized Anxiety Disorder-7: Anxiety severity and treatment monitoring (self-report).
  • ISI — Insomnia Severity Index: Insomnia severity and treatment response (self-report).
  • DAST-10 — Drug Abuse Screening Test: Non-alcohol substance use screening (self-report).

Risk factors to monitor

Acute suicide risk is low: there is no intent or plan, and the patient reports only passive wishes of not waking up when exhausted. Functional risk is significant because tremor affects medication preparation and missed shifts; medical risk remains unanswered while weight loss, heat intolerance, tremor, and diaphoresis require directed assessment.

Reasoning narrative

The panic-like phenomenology is clinically important, but the temporal relationship to sertraline, pseudoephedrine, and high caffeine exposure makes medication- or substance-related anxiety plausible. Objective features and family history keep thyrotoxicosis an important medical alternative.

Rapid thyroid testing, mitigation of stimulant exposures, close follow-up, and practical workplace accommodations are recommended while causal explanations are clarified.

Decision points

What would decide each open question

Every alternative stays paired with the information that would change its place in the formulation. None is treated as settled before that information is available.

Bipolar spectrum disorders

Decisive next data: collateral from family and workplace about any distinct past elevated or expansive mood, decreased need for sleep, or increased goal-directed activity, including its timing relative to sertraline.

Insomnia Disorder and Generalized Anxiety Disorder

Decisive next data: document the duration and frequency of sleep disruption and worry, then reassess whether they persist after medical and medication or substance contributors are addressed.

Anxiety Disorder Due to Another Medical Condition

Decisive next data: obtain vital signs, a focused examination, and TSH/free T4; then assess whether the anxiety and autonomic signs track treatment of any identified thyroid condition.

Thyrotoxicosis (possible hyperthyroidism)

Decisive next data: current TSH and free T4, supported by the focused examination and additional thyroid studies if clinically indicated.

Panic Disorder, provisional

Decisive next data: establish whether recurrent unexpected attacks, anticipatory worry, and avoidance persist after stimulant exposures are removed and medical causes, including thyroid disease, are evaluated.

Thyrotoxicosis / Hyperthyroidism (dangerous to miss)

Decisive next data: rapid vital signs, focused examination, and TSH/free T4 because weight loss, heat intolerance, diaphoresis, tremor, and family history remain unexplained.

Sympathomimetic / stimulant toxicity (dangerous to miss)

Decisive next data: document exposure timing, stop pseudoephedrine and substantially reduce caffeine, observe the short-interval symptom course, and obtain a basic metabolic panel or ECG when clinically indicated.

Primary Panic Disorder with functional impairment (dangerous to miss)

Decisive next data: document attack frequency, unexpectedness, persistent worry, and work avoidance after provoking exposures and medical causes have been addressed.

Relapse of Anorexia Nervosa with medical instability (dangerous to miss)

Decisive next data: assess whether the weight loss is intentional, complete nutritional and medical review, and check vital signs or electrolytes when signs of medical compromise are present.

Cardiac arrhythmia or ischemia (dangerous to miss)

Decisive next data: obtain current vital signs and an ECG when indicated, and ask specifically about syncope, presyncope, exertional worsening, persistent chest pain, or new exertional intolerance.

Bring the same structure to your next case

Run the evidence twice, compare the reads, and keep unresolved medical and substance causes visible in the report.

Start with 3 free analyses

Diagnoxal is educational clinical decision-support. It does not establish a diagnosis or replace professional clinical judgment.

What you get after joining

The member view, on this page

The report format the engine returns, the mind map that ships with the learning module, and all three study surfaces. Real components and real learning paths, shown here.

Report

The formulation a member receives

The case above, as the engine returned it: a headline diagnosis with its status, a differential you can act on, the rule-outs that still need data, the instruments to measure with, and the risk to monitor.

Headline diagnosis

Anxiety Disorder (provisional — etiology undetermined)

Differential diagnoses
  • Bipolar spectrum disorders (Bipolar I / Bipolar II) — evaluation for presence of manic or hypomanic episode RULE OUT
  • Insomnia Disorder (evaluation) AND Generalized Anxiety Disorder (GAD) (evaluation) PROVISIONAL WORKING
  • Anxiety Disorder Due to Another Medical Condition (rule-out: thyrotoxicosis) RULE OUT
Rule-outs (require decisive data before exclusion)
  • Bipolar spectrum disorders (Bipolar I / Bipolar II) — evaluation for presence of manic or hypomanic episode
  • Insomnia Disorder (evaluation) AND Generalized Anxiety Disorder (GAD) (evaluation)
  • Anxiety Disorder Due to Another Medical Condition (rule-out: thyrotoxicosis)
  • Thyrotoxicosis (possible hyperthyroidism)
  • Panic Disorder, provisional (pending evaluation for substance/medical causes)
  • Thyrotoxicosis/Hyperthyroidism (dangerous to miss)
  • Sympathomimetic (pseudoephedrine/caffeine) toxicity with cardiac complications (dangerous to miss)
  • Primary Panic Disorder with functional impairment (dangerous to miss)
  • Relapse of Anorexia Nervosa with medical instability (dangerous to miss)
  • Cardiac arrhythmia/ischemia (dangerous to miss)
Suggested instruments (measurement-based care)
  • C-SSRSColumbia Suicide Severity Rating ScaleStructured suicide risk assessmentclinician-administered
  • MDQMood Disorder QuestionnaireScreening for lifetime manic or hypomanic episodesself-report
  • YMRSYoung Mania Rating ScaleCurrent manic symptom severityclinician-administered
  • GAD-7Generalized Anxiety Disorder-7Anxiety severity and treatment monitoringself-report
  • ISIInsomnia Severity IndexInsomnia severity and treatment responseself-report
  • DAST-10Drug Abuse Screening TestNon-alcohol substance use screeningself-report
Risk factors to monitor

Acute suicide risk is low: the patient denies intent or plan and reports only passive wishes 'wouldn't mind not waking up' when exhausted; there is no history of attempts. Protective factors include employment, supportive nearby parents, and preserved cognition and insight. Functional risk is significant: tremor interfering with drawing medications and missed shifts reflect safety and occupational impairment in a high-stakes environment. Medical risk is unanswered: unexplained 6 kg weight loss, heat intolerance, tremor, and diaphoresis could indicate thyrotoxicosis, which carries systemic risks if untreated. Missing risk data that would change urgency: vital signs, TSH/free T4, and collateral about any prior mood elevation or substance use patterns. Prioritize rapid thyroid testing and mitigation of stimulant exposures; arrange short-interval follow-up and workplace accommodations until safety concerns (tremor, impaired medication preparation) are addressed.

Mind map

81 disorders, conditions, and rule-outs

The study map highlights 141 documented relationships. Choose a category, then a disorder, to fan out what distinguishes it. Amber marks rule-out edges: the relationships a clinician must not miss.

This study map highlights 81 diagnostic concepts and rule-outs informed by DSM-5-TR (APA, 2022) across 15 categories and 141 relationships of five kinds: differential, rule-out, comorbid, spectrum, and shared symptoms. Open it in the learning module.

Practice

Two live previews and a direct Case Practice path

Try one question from the 827-item bank and one card from the 670-card deck here. Case Practice opens its signed-in Learning workspace directly, where you choose a difficulty, submit a diagnosis and reasoning, and review structured feedback.

Quick quiz

One multiple-choice question from the quiz bank, with the engine's own explanation once you answer. Open the quiz bank.

Flashcards

One spaced-repetition card from the deck, front and back. Open the deck.

Case Practice

A complete reasoning exercise

  1. Open a referenced training case at your chosen difficulty.
  2. Submit your diagnosis and reasoning without seeing the answer key.
  3. Review structured feedback, missed evidence, and next steps.
Open Case Practice in Learning

Earlier teaching cases

Two secondary examples are kept in a collapsed archive so the ICU-nurse journey remains the primary demonstration. The PDF below is another format of that same ICU case, not a third story.

Latest Clinical Case Studies

Structured diagnostic reasoning walkthroughs grounded in DSM-5-TR and ICD-11 criteria.

Try one real case

No account is needed for your first analysis. Free accounts include 3 analyses each month.